GenoTwin was founded by leading experts in genomics, computational biology, infectious diseases, and immunology


Connor Dowling
Chief Executive Officer

Previously COO of the BioVenture Entrepreneurship division at Weill Cornell Medicine,
with a focus on commercializing innovative technologies; Master’s from Fletcher School at Tufts


Oliver Elliott
Chief Technology Officer

Previously a software developer in the Department of Systems Biology, Columbia University; Master’s from Columbia University


Reuben Danzing
Chief Financial Officer
& Business Planning

Business Strategist and Founder of FutureSet Strategy LLC, Certified Public Accountant; Master’s from Yale School of Management


Raul Rabadan, PhD

Chief Science Advisor


Professor in Systems Biology and Biomedical Informatics,

Director of the Mathematical Genomics Program, 
Columbia University

hong boon toh.jpg

Hong-Boon Toh

Business Development

Business Development and Commercial Operations, Avatamed


Jae-Hoon Song, MD, PhD


Chairman & CEO of

Mint Venture Partners,

Founder & Chairman, Asia Pacific Foundation for Infectious Diseases


Do-Hyun Nam, MD, PhD



Professor of Neurosurgery; 
Director, Center for Experimental Therapeutics of Samsung Cancer Research Institute; 
Director, Research Center of Future Medicine
Director, Samsung Institute for Refractory Cancer Research

Jessica Rowell - 750_2408-jpg.jpg

Jessica Rowell
Senior Scientist

Computational metagenomics, epidemiology, antimicrobial resistance, and bioinformatics.
MS Bioinformatics, Georgia Institute of Technology,
MPH Epidemiology, Emory University


Alireza Dahaj
Senior Scientist

Ph.D., Computational evolutionary and cancer biology, Georgia Institute of Technology


Brittany Suttner
Senior Scientist

Ph.D., Computational metagenomics, microbial ecology, and bioinformatics, Georgia Institute of Technology. NSF Graduate Research Fellowship

daniel s.tif

Daniel Sunko
Junior Software Engineer

Biochemistry student,

Stony Brook University


We have assembled a world-class Advisory Board to support

product development, market growth, and partnership development.


Arnold Levine

Professor, Institute for Advanced Study, Princeton

  • Member, National Academy of Sciences

  • Known for p53 tumor suppressor protein

  • Numerous awards in biotech and cancer research


Raul Rabadan

Professor in Systems Biology and Biomedical Informatics, Director of the Program for Mathematical Genomics, Columbia University

  • Director of Program for Mathematical Genomics at Colmbia University

  • Current focus on patterns of evolution in biological systems, incl. RNA viruses and cancer

Thomas Shenk.tif

Thomas Shenk

Elkins Professor of Life Sciences, Molecular Biology Dept, Princeton

  • Member, National Academy of Sciences

  • Authority in biochemistry, cell biology, genomics, microbiology, virology

  • Present focus on cytomegalovirus

  • Member of the board of directors of Merck & Co. and the Fox Chase Cancer Center

Stephen Goff.tif

Stephen Goff

Higgins Professor of Microbiology & Immunology and Biochemistry & Molecular Biophysics, Columbia University

  • Member, National Academy of Sciences

  • Authority in molecular biology of retrovirus replication, tyrosine kinases, and signal transduction pathways


Stacey Schultz-Cherry

Member, St. Jude Faculty

  • Authority on influenza and astrovirus pathogenesis, novel vaccines and therapeutics, microbial co-infections

  • Deputy Director, World Health Organization Collaborating Centre for Studies on Ecology of Influenza in Animals and Birds


Dan Notterman

Professor, Senior Research Scholar, and Molecular Biology
Lecturer, Princeton

  • Pediatrician and biologist

  • Primary research focus on understanding genetic variants and environmental signals in the developing behavioral, cognitive and emotional phenotype of children

  • Additional research on genetics of autism


Nina Bhardwaj, MD

Professor of Medicine and Urology, Mount Sinai

  • Director of Immunotherapy, Medical Director of Vaccine and Cell Therapy Lab, and Co-Dir of Cancer Immunology Program at Tisch Cancer Institute

  • Recipient of numerous awards in immunology and cancer

  • Senior Editor for Cancer Immunology Research and Frontiers in Immunology

james musser.jpg

James Musser, MD

Chair, Department of Pathology & Genomic Medicine, Houston Methodist Weill Cornell Medical College

  • Director, Center for Molecular & Translational Human Infectious Diseases Research

  • Research focused on molecular basis of host-pathogen interactions

  • Published more than 300 research articles and book chapters


GenoTwin’s capabilities, opportunities, and geographic reach are magnified by

close collaborations with AIMEDBIO an AVATAMED


AIMEDBIO, South Korea Drug Discovery and Development

Biological drugs: therapeutic antibody, ADC

Gene/Drug Map Assay Technology Development

Samsung Medical Center Spin-off


AVATAMED PTD, Singapore Precision Medicine

In vitro clinical trial for drug development

Global clinical trials (Phases 2, 3)

Singapore A Star Spin-off

Mobile hospital for COVID-19